MedPath

NEO BEX ELIXIR

NEO BEX ELIXIR

Discontinued
DIN Number

00555118

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

neolab inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00555118
AIG Number0626808001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A13A TONICS
Product Specifications
Dosage FormElixir
Route of AdministrationOral
AHFS Classification88:08.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

D-PANTOTHENIC ACID (DEXPANTHENOL)Active
Strength: .08 MG / ML
Monograph: D-PANTOTHENIC ACID (DEXPANTHENOL)
NICOTINAMIDEActive
Strength: .27 MG / ML
Monograph: NICOTINAMIDE
VITAMIN B1 (THIAMINE HYDROCHLORIDE)Active
Strength: .2 MG / ML
Monograph: VITAMIN B1 (THIAMINE HYDROCHLORIDE)
VITAMIN B12Active
Strength: .07 MCG / ML
Monograph: VITAMIN B12
VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM)Active
Strength: .07 MG / ML
Monograph: VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM)
VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)Active
Strength: .02 MG / ML
Monograph: VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.